Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a morbid malignancy with discouraging survival rates. Enthusiasm for pre-operative therapy (chemotherapy, radiation, chemoradiation) in the treatment of PDAC has grown, with many clinical guidelines recommending its use in patients with bord...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Anish J., Maxwell, Jessica E., Katz, Matthew H. G., Snyder, Rebecca A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453019/
https://www.ncbi.nlm.nih.gov/pubmed/37627202
http://dx.doi.org/10.3390/cancers15164174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453019/
https://www.ncbi.nlm.nih.gov/pubmed/37627202
http://dx.doi.org/10.3390/cancers15164174

Ejemplares similares